Synthesis of vancomycin a, b, c, d, and e ring building blocks
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $295,871
Award facts
- Contract value 100% obligated
- $295,871.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $295,871 |
About this award
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Sri International, a non-profit research institute. The contract, valued at $295,871.00, is for the synthesis of vancomycin ring building blocks, which are important compounds for developing new antibiotics. The contract is not set aside for any socioeconomic category. It is a cost-plus-fixed-fee contract, and is a task order under a larger non-clinical services Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Sri International has extensive experience providing research and development services to federal agencies like the Department of Defense, NASA, and HHS through both prime and subcontract arrangements.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 6, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $295,871 on 75N93020F00002.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award